WHO halts hydroxychloroquine trial for coronavirus amid safety fears
by Staff and agencies from Science | The Guardian on (#53X05)
Malaria drug taken by Trump could raise risk of death and heart problems, study shows
The World Health Organization has said it will temporarily drop hydroxychloroquine - the malaria drug Donald Trump said he is taking as a precaution - from its global study into experimental coronavirus treatments after safety concerns.
The WHO's director-general Tedros Adhanom Ghebreyesus said in light of a paper published last week in the Lancet that showed people taking hydroxychloroquine were at higher risk of death and heart problems than those who were not, it would pause the hydroxychloroquine arm of its solidarity global clinical trial.
Continue reading...